Robert Harrington to Disease Progression
This is a "connection" page, showing publications Robert Harrington has written about Disease Progression.
Connection Strength
0.028
-
Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J. 2018 02; 196:28-35.
Score: 0.028